van Rijn, Sander PZuur, Marlanka AAnthony, RichardWilffert, Bobvan Altena, RichardAkkerman, Onno Wde Lange, Wiel C Mvan der Werf, Tjip SKosterink, Jos G WAlffenaar, Jan-Willem C2019-02-202019-02-202019-02-011098-65963045523210.1128/AAC.01489-18http://hdl.handle.net/10029/622822Multi- and extensively drug-resistant tuberculosis (M/XDR-TB) has become an increasing threat not only in countries where the TB burden is high but also in affluent regions, due to increased international travel and globalization. Carbapenems are earmarked as potentially active drugs for the treatment ofeninfo:eu-repo/semantics/closedAccesscarbapenemsclinicalertapenemimipenemin vitroin vivomeropenemtuberculosisArticleAntimicrob Agents Chemother 2019; 63(2):pii.01489-18